Inventor

LONBERG NILS

US70 patents

⚠️ This page may combine multiple inventors who share the name “LONBERG NILS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LONBERG NILS

BRISTOL MYERS SQUIBB CO

Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Antibodies against CD73 and uses thereof

Antibodies against CD73

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors

Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Antibodies comprising modified heavy constant regions

Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to treat tumors

Treatment of LAG-3 positive tumors

GENPHARM INT

Transgenic non-human animals capable of producing heterologous antibodies

Transgenic non-human animals capable of producing heterologous antibodies of various isotypes

Transgenic non-human animals capable of producing heterologous antibodies

Transgenic non-human animals for producing heterologous antibodies

Transgenic non-human animals for producing heterologous antibodies

Transgenic non-human animals capable of producing heterologous antibodies

Transgenic non-human animals capable of producing heterologous antibodies of various isotypes

Transgenic non-human animals capable of producing heterologous antibodies

Transgenic non-human animals for producing heterologous antibodies

Transgenic non-human animals capable of producing heterologous antibodies of various isotypes

Ransgenic non-human animals for producing heterologous antibodies

High affinity human antibodies and human antibodies against human antigens

Heterologous antibodies which bind human CD4

MEDAREX INC

Human CTLA-4 antibodies and their uses

Human CTLA-4 antibodies and their uses

Transgenic non-human animals for producing chimeric antibodies

Human CTLA-4 antibodies

Human antibodies

Human antibodies as detection reagents

BIOSITE INC

Human antibodies

Human antibodies as diagnostic reagents

GENPHARM INTERNAT

Transgenic non-human animals for producing heterologous antibodies

High affinity human antibodies and human antibodies against digoxin

KORMAN ALAN J

Human CTLA-4 antibodies and their uses

Human CTLA-4 antibodies and their uses

LONBERG NILS

Transgenic non-human animals for producing chimeric antibodies

Transgenic non-human animals for producing chimeric antibodies

KYOWA HAKKO KIRIN CO LTD

Transgenic transchromosomal rodents for making human antibodies

Transgenic transchromosomal rodents for making human antibodies

KIRIN BREWERY

Transgenic transchromosomal rodents for making human antibodies

BIOGEN INC

Isolation of exogenous recombinant proteins from the milk of transgenic mammals

PHARMING BV

Transgenic non human mammal milk

CHEN LIANG

Chemical linkers with single amino acids and conjugates thereof

BIOGRAPH 55 INC

Composite binding molecules targeting immunosuppressive B cells

TOMIZUKA KAZUMA

Transgenic trasnchromosomal rodents for making human antibodies